125 related articles for article (PubMed ID: 1983349)
1. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.
Nwokolo CU; Sawyerr A; Smith JT; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349
[TBL] [Abstract][Full Text] [Related]
2. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
3. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
Smith JT; Gavey C; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
Weingart J; Kunert H; Ottenjann R
Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
[TBL] [Abstract][Full Text] [Related]
5. Loss of acid suppression during dosing with H2-receptor antagonists.
Wilder-Smith C; Halter F; Ernst T; Gennoni M; Zeyen B; Varga L; Roehmel JJ; Merki HS
Aliment Pharmacol Ther; 1990; 4 Suppl 1():15-27. PubMed ID: 1983344
[TBL] [Abstract][Full Text] [Related]
6. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
Rogers MJ; Holmfield JH; Primrose JN; Johnston D
Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
[TBL] [Abstract][Full Text] [Related]
7. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
8. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
9. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
[TBL] [Abstract][Full Text] [Related]
10. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
12. The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
Gavey CJ; Smith JT; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1989 Dec; 3(6):557-64. PubMed ID: 2577500
[TBL] [Abstract][Full Text] [Related]
13. Ranitidine inhibits gastric acid and pepsin secretion following sham feeding.
Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
Hepatogastroenterology; 1980 Oct; 27(5):377-80. PubMed ID: 6110626
[TBL] [Abstract][Full Text] [Related]
14. Effect of ranitidine on gastric acid and pepsin secretion following sham feeding.
Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
Scand J Gastroenterol Suppl; 1981 Jun; 69():27-31. PubMed ID: 6119779
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
[TBL] [Abstract][Full Text] [Related]
16. Effect of mifentidine, a new H2-antagonist, on pentagastrin-stimulated acid secretion in healthy subjects.
Lazzaroni M; Ardizzone S; Imbimbo BP; Sangaletti O; Ghirardosi C; Bianchi Porro G
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):218-21. PubMed ID: 2884190
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
19. The new histamine H2-receptor antagonist ranitidine. Duration of action.
Dammann HG; Simon B
Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
[TBL] [Abstract][Full Text] [Related]
20. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
Domschke W; Lux G; Domschke S
Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]